Dr. Michael Broder, President of HEOR consultancy group PHAR, discusses how the COVID-19 pandemic has altered in-person meetings. While there are certainly challenges associated with meeting virtually, there are also some important upsides, especially when utilizing a modified Delphi method to conduct meetings. Dr. Broder discusses on PHAR’s successful transition from traditional in-person to virtual meetings.
Dr. Broder remarks, “Gathering experts and soliciting their advice is a time-honored tactic. But methods for doing so invariably involve meeting in person. Although the threat of COVID-19 appears to be slowly receding, business travel may take years to return to pre-crisis levels. In this climate, how can pharma researchers most effectively leverage advisors?” Read more here.
(Source: Michael Broder, PHAR, HealthEconomics.Com)